NAP1L4 in Hepatocellular Carcinoma Progression and Treatment From Gene Expression to Clinical Impact
To explore the potential mechanisms of NAP1L4 in hepatocellular carcinoma, RNA-seq was performed on LM3 cells with/without NAP1L4 knockdown to detect DEGs.